ABIO,ARCA biopharma, Inc. | Healthcare

Healthcare

ABIO

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

ARCA biopharma, Inc.ABIO

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases.

Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure.

It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19.

ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial.

The company was founded in 2004 and is headquartered in Westminster, Colorado.

Latest News >

US Equity Investors to Watch Out for Magnificent-7 Earnings, Fed's Preferred Inflation Gauge, Tariffs This Week

Jan 27, 2025

05:39 AM EST, 01/27/2025 (MT Newswires) -- US equity investors will focus on earnings from the so-called Magnificent-7 group of stocks this week while watching closely trade policy announcements, the January monetary policy announcement, and the Federal Reserve's preferred inflation data. * Colombia agreed to accept flights of deported migrants from the US on Sunday, hours after President Donald Trump...

TREASURIES-U.S. Treasury yields fall as tech selloff drives safe-haven flows

Jan 27, 2025

LONDON, Jan 27 (Reuters) - U.S. Treasury yields fell to three-week lows on Monday as investors sought the safety of government bonds as tech stocks tumbled on the surging popularity of a Chinese discount artificial intelligence model. The benchmark 10-year Treasury yield dropped 10 basis points to 4.52%, its lowest level since Jan. 2. The two-year yield fell 8 bps...

Ryanair expects Boeing to lift 737 MAX output to 38 a month by end of summer

Jan 27, 2025

(Corrects headline and paragraph 1 to show forecast referred to production, not deliveries) DUBLIN (Reuters) - Ryanair expects Boeing ( BA ) to produce 38 of its 737 MAX planes per month by the end of the summer and possibly up to 42 by October, subject to U.S. Federal Aviation Administration approval, Ryanair CEO Michael O'Leary said on Monday. O'Leary...

ASML, Nvidia, Other Tech Stocks Fall After Chinese AI Startup Releases Open-Source Model

Jan 27, 2025

05:40 AM EST, 01/27/2025 (MT Newswires) -- ASML Holding ( ASML ) , Nvidia ( NVDA ) and other technology stocks were down sharply in Monday's premarket activity after Chinese artificial intelligence startup DeepSeek released an open-source AI model that it said can run on less sophisticated chips. ASML ( ASML ) fell more than 10% pre-bell while Nvidia (...